Resultats de la cerca - Xuejun Chen
- Mostrar 1 - 20 resultats de 62
- Anar a la pàgina següent
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Pharmacokinetics of Ruxolitinib in Patients with Atopic Dermatitis Treated With Ruxolitinib Cream: Data from Phase II and III Studies per Xiaohua Gong, Xuejun Chen, Michael E. Kuligowski, Xing Liu, Xiang Liu, Evan Cimino, Ryan McGee, Swamy Yeleswaram
Publicat 2021Artigo -
14
Construction of a diagnostic model utilizing m7G regulatory factors for the characterization of diabetic nephropathy and the immune microenvironment per Jingying Zhong, Pengli Xu, Xuanyi Li, Meng Wang, Xuejun Chen, Huiyu Liang, Zedong Chen, Jing Yuan, Ya Xiao
Publicat 2025Artigo -
15
-
16
Construction and validation of a risk stratification model based on Lung-RADS® v2022 and CT features for predicting the invasive pure ground-glass pulmonary nodules in China per Qingcheng Meng, Tong Liu, Hui Peng, Pengrui Gao, W. C. Chen, Min Fang, Wentao Liu, Hong Ge, Renzhi Zhang, Xuejun Chen
Publicat 2025Artigo -
17
Antimicrobial peptides human β‐defensin (hBD)‐3 and hBD‐4 activate mast cells and increase skin vascular permeability per Xuejun Chen, François Niyonsaba, Hiroko Ushio, Mutsuko Hara, Hidenori Yokoi, Kenji Matsumoto, Hirohisa Saito, Isao Nagaoka, Shigaku Ikeda, Ko Okumura, Hideoki Ogawa
Publicat 2007Artigo -
18
Phase 1 study of the PI3Kδ inhibitor INCB040093 ± JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma per Tycel Phillips, Andres Forero‐Torres, Taimur Sher, Catherine Diefenbach, Patrick B. Johnston, Moshe Talpaz, Jennifer Pulini, Li Zhou, Peggy Scherle, Xuejun Chen, Paul M. Barr
Publicat 2018Artigo -
19
A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consorti... per Mignon L. Loh, Sarah K. Tasian, Karen R. Rabin, Patrick A. Brown, Daniel Magoon, Joel M. Reid, Xuejun Chen, Charlotte H. Ahern, Brenda J. Weigel, Susan M. Blaney
Publicat 2015Artigo -
20
<scp>PD</scp>‐1 inhibition with retifanlimab and/or arginase inhibition with <scp>INCB001158</scp> in Japanese patients with solid tumors: A phase I study per Yasutoshi Kuboki, Takafumi Koyama, Nobuaki Matsubara, Yoichi Naito, Shunsuke Kondo, Kenichi Harano, Kan Yonemori, Kiyotaka Yoh, Gu Yuan, Tetsuya Mita, Xuejun Chen, Eiji Ueda, Noboru Yamamoto, Toshihiko Doi, Toshio Shimizu
Publicat 2024Artigo
Eines de cerca:
Matèries relacionades
Biology
Antibody
Immunology
Virology
Medicine
Neutralizing antibody
Genetics
Virus
Internal medicine
Neutralization
Biochemistry
Gene
Human immunodeficiency virus (HIV)
Chemistry
Glycoprotein
Immune system
Cell biology
Epitope
Monoclonal antibody
Glycan
Simian immunodeficiency virus
Immunization
In vitro
Oncology
In vivo
Adverse effect
Computer science
HIV vaccine
Organic chemistry
Pharmacology